2D)
2D). to their relationships with monomeric A42 and strongly dependent on their ability to convert into amyloid fibrils. Subfractionation of (S,R,S)-AHPC hydrochloride protofibrils diminished their fibrillization and toxicity, whereas reintroduction of monomeric A42 into purified protofibril fractions restored amyloid formation and enhanced their toxicity. Selective removal of monomeric A42 from these preparations, using insulin-degrading enzyme, reversed the toxicity of A42 protofibrils. Collectively, our findings demonstrate that A42 toxicity is not linked to specific prefibrillar aggregate(s) but rather to the ability of these varieties to grow and undergo fibril formation, which depends on the presence of monomeric A42. These findings contribute significantly to the understanding of amyloid formation and toxicity in Alzheimer disease, provide novel insight into mechanisms of A protofibril toxicity, and important implications for developing anti-amyloid therapies. Keywords:Alzheimer Disease, Amyloid, Cell Death, Neurodegeneration, Protein Self-assembly, Nucleated Polymerization, Oligomers == Intro == Aggregation of amyloid- (A)2peptides and deposition into neuritic plaques are hallmark features of Alzheimer disease (AD) neuropathology (1,2). Consequently, research efforts during the past 3 decades have focused on elucidating the mechanisms of A fibrillization, identifying harmful varieties, and developing strategies to inhibit and/or reverse A amyloid formation and toxicityin vivo(3,4). A (S,R,S)-AHPC hydrochloride peptides are produced as soluble monomers (5,6) and undergo oligomerization and amyloid fibril formation via a nucleation-dependent polymerization process (7,8). During the program ofin vitroA fibril formation, numerous nonfibrillar aggregation intermediates, collectively called soluble oligomers or protofibrils, have been shown to precede the emergence of fibrils. Increasing evidence from numerous sources points to A oligomers/protofibrils as putative harmful varieties in AD pathogenesis and suggests that these varieties are potential restorative targets for treating AD (examined in Refs.9,10). Even though harmful oligomer hypothesis offers emerged as one of the major current operating hypotheses in AD research, the development of effective diagnostic tools and therapies on the basis of this hypothesis offers yet to be realized (1113). This is partially due to the fact that recognition of a single harmful A varieties that correlates with AD progression and severity remains elusive. Furthermore, the exact mechanisms by which these varieties contribute to A toxicityin vivoand the nature of the harmful varieties are not yet fully understood. Recent evidence suggests that accelerating the process of A fibrillization greatly enhances A toxicityin vitro(14) and the spread of amyloid pathologyin vivo(1517). Despite significant attempts by different organizations to isolate specific intermediates along the (S,R,S)-AHPC hydrochloride amyloid formation pathway (12,1822), the inherent heterogeneity of the process and metastable nature of A oligomers (1113) have precluded the isolation of a single harmful varieties. Unless covalently cross-linked (23), A oligomers do not exist as stable entities,i.e.they evolve into higher order aggregates and, if they are on-pathway intermediates, convert into fibrils (19). Consequently, it is plausible to (S,R,S)-AHPC hydrochloride presume that the structural dynamics of oligomers and factors that govern their interconversion and/or growth might influence some of the disease-related cytotoxic effects of A. In other words, an ongoing polymerization process involving the NOTCH2 elongation and growth of oligomers, rather than the formation of a stable oligomeric varieties, may become responsible for A toxicity and neurodegeneration in AD. To test this hypothesis, we developed different methods to isolate A varieties of defined size and morphology distribution (24), and we investigated their toxicity in different cell lines and main neurons. We observed that crude A42 preparations, comprising a monomeric and heterogeneous mixture of A42 oligomers and protofibrils, were more harmful than the purified monomeric protofibrillar fractions or fibrils. The toxicity of protofibrils was directly linked to their relationships with monomeric A42 and strongly dependent on their ability to convert into amyloid fibrils. Selective removal of the monomers, by SEC or by degradation with insulin-degrading enzyme (IDE), retarded the elongation of protofibrils, their fibrillization, and diminished protofibril toxicity toward cultured rat main neurons, pheochromocytoma (Personal computer12) cells, and neuroblastoma (SHSY5Y) cells. Similarly, we show that an.